Abiopharma

🔍 Hsieh Ming (Executive)

Company: Fulgent Genetics, Inc. (FLGT)

Report Date: 2025-08-23

Detailed Transactions and Holdings:

• Sold 2,115 shares of Common Stock at $21.77 per share (Direct)
  Date: 2025-08-23 | Code: F | equity_swap_involved: false | shares_owned_after: 807,225.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-23 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 7,895,115.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-23 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 220,816.00 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-23 | Code: H | nature_of_ownership: Uniform Transfer to Minor Account | shares_owned_after: 1,000.00 | Footnotes: F4
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-23 | Code: H | nature_of_ownership: Uniform Transfer to Minor Account | shares_owned_after: 1,000.00 | Footnotes: F4

Footnotes:

• F1: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023.
• F2: Securities held by the Dynasty Trust. Mr. Hsieh is the grantor of the Dynasty Trust and he and his spouse, Eva Hsieh, and Jian Xie serve on the investment committee of the Dynasty Trust. Mr. Hsieh disclaims any beneficial interest except with respect to any pecuniary interest therein.
• F3: Securities held by The Ming Hsieh Trust (the "Hsieh Trust"). Mr. Hsieh is the trustee of the Hsieh Trust and possesses the sole voting and dispositive power with respect to securities held by the Hsieh Trust.
• F4: Shares held in a Uniform Transfers to Minor Act account for which Ming Hsieh acts as custodian and possesses the sole voting and dispositive power.